Skip to content
★ Sign in to follow
CS

Cheryl Scott

Board Director
Director
Insider activity · 24 months0 buys1 saleCumulative net flow
Total declarations
29
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€707k

Latest filing published 12 Jun 2025 for Progyny, Inc., €51k.

Filing timeline

BuySale
Cheryl Scott

Insider track record

Disclosed buys
0
Disclosed sells
10
Signal history

Cheryl Scott: trading record in brief

Cheryl Scott, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Evolent Health, Inc. and Progyny, Inc. We count 29 filings; the first trade dates from 10 November 2015 and the latest from 11 June 2025.

Sales make up the whole of the open-market record (10 sales, €707k). Outside the open market, there are 17 share grants. 2025 to date brings no purchases and 1 sale.

Most recently, on 12 June 2025, the filings show an open-market sale worth €51k in Progyny, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Cheryl Scott

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations29 total

25 of 29 declarations